Group One Trading’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Group One Trading’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,066	Closed	-$352	–	8451
2023 Q1	$352	Hold	1,066	–	–	﹤0.01%	6950
2022 Q4	$768	Hold	1,066	–	–	﹤0.01%	6887
2022 Q3	$1K	Hold	1,066	–	–	﹤0.01%	7422
2022 Q2	$1K	Hold	1,066	–	–	﹤0.01%	7676
2022 Q1	$2K	Sell	1,066 -421	-28%	-$684	﹤0.01%	7777
2021 Q4	$2K	Hold	1,487	–	–	﹤0.01%	7938
2021 Q3	$4K	Hold	1,487	–	–	﹤0.01%	7841
2021 Q2	$5K	Hold	1,487	–	–	﹤0.01%	7793
2021 Q1	$6K	Hold	1,487	–	–	﹤0.01%	7212
2020 Q4	$5K	Hold	1,487	–	–	﹤0.01%	6054
2020 Q3	$10K	Sell	1,487 -51	-3%	-$346	﹤0.01%	5440
2020 Q2	$11K	Buy	+1,538	New	+$10.5K	﹤0.01%	5100
2020 Q1	–	Sell	-1,103	Closed	-$11.8K	–	5921
2019 Q4	$14K	Hold	1,103	–	–	﹤0.01%	4499
2019 Q3	$12K	Hold	1,103	–	–	﹤0.01%	4549
2019 Q2	$19K	Buy	1,103 +470	+74%	+$12.7K	﹤0.01%	4201
2019 Q1	$21K	Sell	633 -280	-31%	-$9.36K	﹤0.01%	4020
2018 Q4	$27K	Sell	913 -584	-39%	-$25.9K	﹤0.01%	3888
2018 Q3	$92K	Sell	1,497 -1,051	-41%	-$71.1K	﹤0.01%	3596
2018 Q2	$188K	Buy	2,548 +2,367	+1,308%	+$184K	﹤0.01%	3103
2018 Q1	$12K	Sell	181 -83	-31%	-$6.27K	﹤0.01%	4271
2017 Q4	$22K	Sell	264 -1,593	-86%	-$156K	﹤0.01%	4117
2017 Q3	$215K	Buy	1,857 +1,549	+503%	+$163K	﹤0.01%	2710
2017 Q2	$36K	Buy	+308	New	+$38.2K	﹤0.01%	3671
2017 Q1	–	Sell	-80	Closed	-$10.5K	–	5126
2016 Q4	$11K	Buy	80 +20	+33%	+$3.55K	﹤0.01%	3921
2016 Q3	$12K	Buy	+60	New	+$10.3K	﹤0.01%	3999
2016 Q1	–	Sell	-309	Closed	-$63K	–	5075
2015 Q4	$63K	Buy	+309	New	+$55.3K	﹤0.01%	3282
2015 Q3	–	Sell	-104	Closed	-$22K	–	5303
2015 Q2	$22K	Buy	+104	New	+$25.5K	﹤0.01%	3992

Other funds holding BLCM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Group One Trading's BLCM Position: Q2 2023 in Review

Group One Trading sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 1,066 shares — an estimated $352 sold.

Group One Trading first reported a position in BLCM in Q2 2015 and held it in 27 quarters. The position peaked at $215K in Q3 2017. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

Group One Trading reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 1,066 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $352.
Group One Trading first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 27 quarters.
Group One Trading's Bellicum Pharmaceuticals, Inc. position peaked at $215K in Q3 2017.
4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.